Edition:
United States

QUIDEL ANNOUNCES EARLY TERMINATION OF HART-SCOTT-RODINO WAITING PERIOD ON DEAL FOR ALERE'S ASSAY BUSINESS


Thursday, 28 Sep 2017 02:00pm EDT 

Sept 28 (Reuters) - Quidel Corp ::QUIDEL ANNOUNCES EARLY TERMINATION OF THE HART-SCOTT-RODINO WAITING PERIOD FOR ITS PENDING ACQUISITION OF ALERE’S TRIAGE® B-TYPE NATURIETIC PEPTIDE (BNP) ASSAY BUSINESS RUN ON BECKMAN COULTER ANALYZERS.QUIDEL-GETS NOTICE FROM FTC GRANTING EARLY TERMINATION OF WAITING PERIOD UNDER HART-SCOTT-RODINO ACT FOR CO'S PENDING ACQUISITION OF ALERE'S ASSAY BUSINESS.QUIDEL - CO'S ACQUISITION OF ALERE'S TRIAGE METERPRO BUSINESS IS NOT AFFECTED BY EARLY TERMINATION OF WAITING PERIOD UNDER HART-SCOTT-RODINO.